10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A series of new carbohydrate-based sulphonamide derivatives were designed, synthesised by employing the so-call ‘sugar-tail’ approach. The compounds were evaluated in vitro against a panel of CAs. Compared to their parent compound p-sulfamoylbenzoic acid, these compounds showed nearly 100-fold improvement in their binding affinities against hCA II in vitro. All of compounds showed great water solubility and the pH value of their water solutions of compounds is 7.0. Such properties are advantageous to make them much less irritating to the eye when applied topical glaucomatous drugs, compared to the relatively highly acidic dorzolamide preparations (pH 5.5). Notably, compounds 7d, 7 g, 7 h demonstrated to topically lower intraocular pressure (IOP) in glaucomatous animals better than brinzolamide when applied as a 1% solution directly into the eye. Low cytotoxicity on human cornea epithelial cell was observed in the tested concentrations by the MTT assay.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Carbonic anhydrase inhibitors.

          At least 14 different carbonic anhydrase (CA, EC 4.2.1.1) isoforms were isolated in higher vertebrates, where these zinc enzymes play crucial physiological roles. Some of these isozymes are cytosolic (CA I, CA II, CA III, CA VII), others are membrane-bound (CA IV, CA IX, CA XII, and CA XIV), CA V is mitochondrial and CA VI is secreted in saliva. Three acatalytic forms are also known, which are denominated CA related proteins (CARP), CARP VIII, CARP X, and CARP XI. Several important physiological and physio-pathological functions are played by many CA isozymes, which are strongly inhibited by aromatic and heterocyclic sulfonamides as well as inorganic, metal complexing anions. The catalytic and inhibition mechanisms of these enzymes are understood in detail, and this helped the design of potent inhibitors, some of which possess important clinical applications. The use of such enzyme inhibitors as antiglaucoma drugs will be discussed in detail, together with the recent developments that led to isozyme-specific and organ-selective inhibitors. A recent discovery is connected with the involvement of CAs and their sulfonamide inhibitors in cancer: several potent sulfonamide inhibitors inhibited the growth of a multitude of tumor cells in vitro and in vivo, thus constituting interesting leads for developing novel antitumor therapies. Furthermore, some other classes of compounds that interact with CAs have recently been discovered, some of which possess modified sulfonamide or hydroxamate moieties. Some sulfonamides have also applications as diagnostic tools, in PET and MRI or as antiepileptics or for the treatment of other neurological disorders. Future prospects for drug design applications for inhibitors of these ubiquitous enzymes are also discussed. Copyright 2002 Wiley Periodicals, Inc.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Esterase activities of human carbonic anhydrases B and C.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Antiglaucoma carbonic anhydrase inhibitors: a patent review.

              Glaucoma is one of the major causes of blindness, affecting together with age-related macular degeneration > 70 million people worldwide. One of the therapeutic options for its management is based on the inhibition of the metalloenyme carbonic anhydrase (CA, EC 4.2.1.1). CA inhibitors (CAIs) diminish intraocular pressure (IOP) by reducing the rate of bicarbonate formation and thus secretion of the aqueous humor.
                Bookmark

                Author and article information

                Journal
                J Enzyme Inhib Med Chem
                J Enzyme Inhib Med Chem
                IENZ
                ienz20
                Journal of Enzyme Inhibition and Medicinal Chemistry
                Taylor & Francis
                1475-6366
                1475-6374
                2020
                22 December 2019
                : 35
                : 1
                : 383-390
                Affiliations
                Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University , Shenyang, China
                Author notes

                Supplemental data for this article can be accessed here .

                CONTACT Yang Liu y.liu@ 123456syphu.edu.cn ;
                Bin Lin randybinlin@ 123456gmail.com Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University , Shenyang, 110016, China
                Author information
                http://orcid.org/0000-0002-4933-4226
                http://orcid.org/0000-0002-9284-1944
                Article
                1705293
                10.1080/14756366.2019.1705293
                6968511
                31865756
                0c86c491-f046-43e6-a5ce-6bc20ded7d25
                © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 10 October 2019
                : 03 December 2019
                : 05 December 2019
                Page count
                Figures: 5, Tables: 2, Pages: 8, Words: 5890
                Funding
                Funded by: National Natural Science Foundation of China 10.13039/501100001809
                Award ID: 81903463
                Funded by: Department of Education of Liaoning Province 10.13039/501100007620
                Award ID: 2017LQN03
                Funded by: Department of Science and Technology of Liaoning Province 10.13039/501100004767
                Award ID: 20180540032
                The authors appreciate the financial supports from the National Natural Science Foundation of China [No. 81903463], Department of Education of Liaoning Province [2017LQN03] and Department of Science and Technology of Liaoning Province [20180540032].
                Categories
                Research Paper

                Pharmaceutical chemistry
                carbonic anhydrase ii inhibitors,sugar tail,hydrophilic half,antiglaucoma

                Comments

                Comment on this article